I have an article in the latest INCOSE Preview (see page 31), discussing the rise of the Internet of Things (IoT) in the context of Medical Devices. I argue that, when it comes to connected features, keeping ahead of the industry arms race is made especially tricky by the gradual settling of the regulatory environment, but that progress can still be made in the face of uncertainty given a flexible approach based on good systems thinking.

Vicky Bunyard's discussion of IoT security and adoption of an immune system model is also very interesting, although it raises questions over how far the death of individual cells in an organism or members of a population is important in ensuring immunity of the whole, and what the effects of autoimmune-like responses would be, where generally-targeted security features begin to interfere unpredictably with intended interaction between devices. From the Medical Devices point of view, this adds further to the unpredictability of the platform, making risk management slightly more involved.